TradingView
RocketTickers
Oct 27, 2020 7:04 PM
Vanda Pharmaceuticals Receives FDA Approval to Proceed with Inve
Long
NASDAQ:VNDA
60
Vanda Pharmaceuticals Inc.
NASDAQ
Description
⋅
Oct 27, 2020 7:04 PM
VNDA: Vanda Pharmaceuticals Inc.
2020-10-26 16:01:00
Vanda Pharmaceuticals Receives FDA Approval to Proceed with Investigational New Drug VSJ-110 for Allergic Conjunctivitis
Beyond Technical Analysis
More